These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 8637015)

  • 41. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
    Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
    J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based understanding of ligand affinity using human thrombin as a model system.
    Nienaber VL; Mersinger LJ; Kettner CA
    Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
    Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
    Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8A resolution.
    Zhu Y; Huang Q; Chi C
    J Biomol Struct Dyn; 1999 Jun; 16(6):1219-24. PubMed ID: 10447205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
    Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
    J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
    Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
    J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
    Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
    Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A fluorescent probe for the active site of bovine trypsin.
    Russo SF; Morris DN
    Physiol Chem Phys Med NMR; 1983; 15(3):223-7. PubMed ID: 6675024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of lysine 60f to S1' specificity of thrombin.
    Rezaie AR; Olson ST
    Biochemistry; 1997 Feb; 36(5):1026-33. PubMed ID: 9033392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of the Kunitz-type trypsin inhibitor DE-3 from Erythrina caffra seeds to serine proteinases: a comparative study.
    Onesti S; Matthews DJ; Aducci P; Amiconi G; Bolognesi M; Menegatti E; Ascenzi P
    J Mol Recognit; 1992 Sep; 5(3):105-14. PubMed ID: 1298302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
    Krishnan R; Mochalkin I; Arni R; Tulinsky A
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
    Sherawat M; Kaur P; Perbandt M; Betzel C; Slusarchyk WA; Bisacchi GS; Chang C; Jacobson BL; Einspahr HM; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):500-7. PubMed ID: 17372355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.
    Bone R; Lu T; Illig CR; Soll RM; Spurlino JC
    J Med Chem; 1998 Jun; 41(12):2068-75. PubMed ID: 9622548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.